(OC-6-33)-[4,4′-bis(trifluoromethyl)-2,2′-bipyridine-κN1,κN1′]bis[5-(1,1-dimethylethyl)-2-[4-(1,1-dimethylethyl)-2-pyridinyl-κN]phenyl-κC]-Iridium(1+),hexafluorophosphate(1-) (1:1)

Catalog No. :
ACQLZK153
CAS No. :
2757085-13-3
Molecular Formula :
-
Molecular Weight :
1162.18

IUPAC Name:-

(OC-6-33)-[4,4′-bis(trifluoromethyl)-2,2′-bipyridine-κN1,κN1′]bis[5-(1,1-dimethylethyl)-2-[4-(1,1-dimethylethyl)-2-pyridinyl-κN]phenyl-κC]-Iridium(1+),hexafluorophosphate(1-) (1:1) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$161.00Login to see priceIn stockInquiry
100mg97%$249.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(OC-6-33)-[4,4′-bis(trifluoromethyl)-2,2′-bipyridine-κN1,κN1′]bis[5-(1,1-dimethylethyl)-2-[4-(1,1-dimethylethyl)-2-pyridinyl-κN]phenyl-κC]-Iridium(1+),hexafluorophosphate(1-) (1:1)
Molecular Weight1162.18
SMILESFC(F)(F)C1=CC=[N]2C(=C1)C=3C=C(C=C[N]3[Ir+3]452([C-]6=CC(=CC=C6C7=CC(=CC=[N]74)C(C)(C)C)C(C)(C)C)[C-]8=CC(=CC=C8C9=CC(=CC=[N]95)C(C)(C)C)C(C)(C)C)C(F)(F)F.[F-][P+5]([F-])([F-])([F-])([F-])[F-]
InChI KeyBUWMDJMZZJZFEK-UHFFFAOYSA-N
SynonymIridium(1+), [4,4'-bis(trifluoromethyl)-2,2'-bipyridine-κN1,κN1']bis[5-(1,1-dimethylethyl)-2-[4-(1,1-dimethylethyl)-2-pyridinyl-κN]phenyl-κC]-, (OC-6-33)-, hexafluorophosphate(1-) (1:1);Bis[4-tert-butyl-2-(4-tert-butylphenyl)pyridine][4,4'-bis(trifluoromethyl)-2,2'-bipyridine] iridium(III) hexafluorophosphate;(OC-6-33)-[4,4′-bis(trifluoromethyl)-2,2′-bipyridine-κN1,κN1′]bis[5-(1,1-dimethylethyl)-2-[4-(1,1-dimethylethyl)-2-pyridinyl-κN]phenyl-κC]-Iridium(1+),hexafluorophosphate(1-) (1:1);Ir[tBu(tBu)ppy]2(4,4'-dCF3bpy)PF6
CAS No.2757085-13-3
PubChem CID165430922

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Comments (0)